<DOC>
	<DOCNO>NCT03091062</DOCNO>
	<brief_summary>The aim study ass effectiveness Airway Clearance System .</brief_summary>
	<brief_title>Evaluation Airway Clearance System</brief_title>
	<detailed_description>The study compare effectiveness The Monarch™ System The Vest® Airway Clearance System . All subject receive treatment system endpoint compare .</detailed_description>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Documented diagnosis Cystic Fibrosis ( CF ) ( sweat test and/or genetics ) Age ≥ 15 year Ability expectorate sputum daily determine treat physician Patient must stable regimen CF medication 4 week Patient require regular home airway clearance therapy Forced Expiratory Volume 1 Second ( FEV1 ) &lt; 30 % predict &gt; 90 % predict Anticipated requirement hospitalization within next three week History pneumothorax within past 6 month prior History haemoptysis require embolization within past 12 month Inability perform Monarch™ and/or Vest® System therapy direct Unable unwilling complete study visit provide followup data require per study protocol Has take Intravenous ( IV ) antibiotic within past 4 week prior Visit 1 Has ongoing exacerbation Allergic bronchopulmonary aspergillosis ( ABPA ) Pregnant lactate female</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>